J-TRC onsite study

J-TRC onsite study - J-TRC-OS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038711

Enrollment

1200

Registered

2020-01-15

Start date

2020-02-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preclinical and prodromal Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Provision of signed and dated informed consent form 2. Stated availability and willingness to comply with all study procedures until referred to a clinical trial 3. Age 50-85 (inclusive) 4. Global CDR score of 0 or 0.5 and no diagnosis of dementia.

Exclusion criteria

Exclusion criteria: 1. Treatment with another anti-amyloid investigational drug or other intervention within 12 months (exception allowed) 2. Enrolled in another interventional clinical trial within the last 12 weeks

Design outcomes

Primary

Measure	Time frame
Evaluation of amyloid risk scores based on cognitive scores (e.g., PACC), APOE genotype, family history, age etc.	—

Countries

Japan

Contacts

Public ContactTakeshi Iwatsubo

The University of Tokyo Neuropathology

iwatsubo@m.u-tokyo.ac.jp03-5841-3541

Outcome results